Prostate Cancer Hot Flashes ADT Smartwatch Feasibility Study
Summary
NIH ClinicalTrials.gov registered a new feasibility study (NCT07535541) titled 'A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer.' The study will evaluate whether prostate cancer patients on ADT with vasomotor symptoms (hot flashes) consistently wear a smartwatch device to track health data and log hot flashes. Participants will wear the smartwatch for 4 weeks and complete surveys about their hot flash experiences. No compliance obligations are created for organizations.
What changed
NIH ClinicalTrials.gov added a new feasibility study registration (NCT07535541) for a device-based monitoring study in prostate cancer patients experiencing hot flashes from androgen deprivation therapy. The study will assess patient compliance with wearing a smartwatch to track health data and log vasomotor symptoms over a 4-week period, with comparison to daily survey responses.
This registry entry does not create compliance obligations for any organization. Clinical investigators conducting device trials and healthcare providers should monitor ClinicalTrials.gov for updates. Sponsors of similar clinical investigations may find this registry entry relevant to ongoing competitive landscape awareness.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
N/A NCT07535541 Kind: NA Apr 17, 2026
Abstract
The purpose of this study is to find out if patients with prostate cancer who have vasomotor symptoms, commonly called hot flashes, from their Androgen Deprivation Therapy (ADT) will consistently wear a smartwatch device to track their health data, log hot flashes on their smartwatch, and how these data compare with daily surveys about their hot flashes. Participants will be asked to wear the smartwatch for 4 weeks and to log their hot flashes on their smart watch pressing a button on the watch. Participants will be asked to complete surveys (sent through a text message link) to describe their experiences with hot flashes.
Conditions: Prostate Cancer, Hot Flashes
Interventions: VMS logging
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.